无论是小成年人还是大孩子:对脑瘤的TYAs做得更好
Timothy A Ritzmann1,2, Rebecca Hodgkinson2, Shaarna Shanmugavadivel3
1Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, United Kingdom.
概括
诊断延迟阻碍了对年轻患者高度质瘤的分子洞察力的使用. 减少这些长时间的诊断间隔对于改善青少年和成人脑瘤患者的治疗结果至关重要.
科学领域:
- 神经瘤学神经瘤学
- 儿科瘤学 儿科瘤学
- 分子诊断学 分子诊断学
背景情况:
- 青少年和年轻成年人的高度质瘤 (HGGs) 需要及时诊断.
- 分子分析的进步提供了新的治疗点.
- 目前的诊断途径可能没有为这个年龄组优化.
研究的目的:
- 突出年轻HGG患者延长诊断间隔的挑战.
- 倡导减少诊断时间,以利用分子洞察力.
- 强调需要改善儿科和年轻成人神经瘤学的临床工作流程.
主要方法:
- 对青少年和年轻成年人HGGs的当前诊断时间表的审查.
- 分析诊断延迟对治疗开始的影响.
- 讨论快速分子分析的潜在好处.
主要成果:
- 在青少年和年轻成年人中,HGGs的诊断间隔通常是长时间的.
- 延迟诊断可能会阻碍及时应用向分子疗法.
- 较短的诊断时间对于最大限度地提高分子发现的临床效用至关重要.
结论:
- 缩短诊断间隔是从年轻HGG患者的分子见解中受益的关键步骤.
- 优化诊断途径对于青少年和年轻人的有效神经瘤治疗是必要的.
- 需要进一步的研究和临床努力来简化这个人群的诊断过程.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675


